肝胆胰外科杂志 ›› 2021, Vol. 33 ›› Issue (7): 419-.doi: 10.11952/j.issn.1007-1954.2021.07.007

• 短篇论著 • 上一篇    下一篇

LC联合LCHTD治疗胆总管结石合并胆囊结石的效果及术后胆总管结石复发的相关因素分析

尼加提江·艾比不拉1,阿力木江·阿布力米提1,阿里旦·艾尔肯1,阿依甫汗·阿汗2   

  1. 新疆医科大学第一附属医院,新疆 乌鲁木齐 830054,1.全科医学科,2.肝胆包虫科
  • 收稿日期:2021-03-10 出版日期:2021-07-15 发布日期:2021-07-21
  • 作者简介:尼加提江·艾比不拉(1990-),男,新疆哈密人,住院医师,硕士。

Efficacy of LC combined with LCHTD in treatment of choledocholithiasis complicated with cholecystolithiasis and the related factors of postoperative recurrence of choledocholithiasis

NIJIATIJIANG Aibibula1, ALIMUJIANG Abulimiti1, ALIDAN Aierken1, AYIPUHAN Ahan2   

  1. 1Department of General Medicine, 2Department of Hepatobiliary Echinococcidae, the First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China
  • Received:2021-03-10 Online:2021-07-15 Published:2021-07-21

摘要:

目的 探讨腹腔镜胆囊切除(LC)联合腹腔镜胆总管切开取石T管引流术(LCHTD)治疗胆总管结石合并胆囊结石的效果及术后胆总管结石复发的相关因素。方法 回顾性分析2018 年1 月至2019 年1 月新疆医科大学第一附属医院93 例胆总管结石合并胆囊结石患者临床资料,所有患者均给予LC联合LCHTD治疗。根据是否术后胆总管结石复发分为结石复发组(24例)和结石未复发组(69例),观察两组临床疗效、手术时间、术中出血量、总住院时间、住院费用,随访术后胆总管结石复发情况,分析术后胆总管结石复发的危险因素。结果 93例患者LC联合LCHTD治疗手术成功90 例,中转开腹3 例。手术时间(109.4±10.6)min,术中出血量(80.2±19.1)mL,总住院时间(9.2±1.2)d,住院费用(1.9±0.4)万元。所有患者均完成随访18个月,术后胆总管结石复发24例(25.81%),平均复发时间为(10.3±2.1)个月。结石未复发组剔除中转开腹3 例,单因素分析表明,结石复发组和结石未复发组患者年龄、性别、病程、结石直径差异无统计学意义(P>0.05);胆总管结石类型、结石数量、胆总管直径、碎石术、胆总管扩张、胆囊管扩张、合并炎症与胆总管结石合并胆囊结石术后胆总管结石复发相关(P<0.05);多因素非条件Logistic分析显示,结石数量、胆总管直径、碎石术、胆总管扩张、胆囊管扩张、合并炎症是胆总管结石合并胆囊结石术后胆总管结石复发的独立危险因素(P<0.05)。结论 在胆总管结石合并胆囊结石患者中应用LC联合LCHTD疗效显著,术后结石复发受多种因素影响,积极干预可有效降低结石复发率。

关键词: 胆总管结石合并胆囊结石;腹腔镜胆囊切除术(LC);腹腔镜胆总管切开取石T管引流术(LCHTD);结石复发
 ,
 ,  ,  

Abstract:

Objective To study the efficacy of laparoscopic cholecystectomy (LC) combined with laparoscopic choledocholithotomy and T-tube drainage (LCHTD) in treatment of choledocholithiasis complicated with cholecystolithiasis and the related factors of postoperative recurrence of choledocholithiasis. Methods A total of 93 patients with choledocholithiasis and cholecystolithiasis admitted in the First Affiliated Hospital of Xinjiang Medical University between Jan. 2018 and Jan. 2019 were retrospectively analyzed. All patients were treated with LC combined with LCHTD. According to the postoperative recurrence of choledocholithiasis, they were divided into recurrence group (n=24) and non recurrence group (n=69), Clinical efficacy, operative time, intraoperative blood loss, time and cost of hospitalization were observed. Postoperative recurrence of choledocholithiasis was followed-up, and the risk factors for postoperative recurrence of choledocholithiasis were analyzed. Results In all 93 patients, 90 cases were successfully operated, and 3 cases were converted to laparotomy. The operation time was (109.4±10.6)min, intraoperative blood loss was (80.2±19.1)mL, the total hospitalization time was (9.2±1.2)d, and the cost was (1.9±0.4) ten thousand yuan. All patients were followed-up for 18 months. 24 patients (25.81%) had postoperative recurrence of choledocholithiasis. The average recurrence time was (10.3±2.1)months. Three cases in non recurrencc group were excluded. Univariate analysis showed that there were no significant differences in age, gender, course of disease and stone diameter between recurrence group and non recurrence group (P>0.05). Type and number of calculi, diameter of common bile duct, lithotripsy, dilatation of common bile duct, dilatation of cystic duct and inflammation were correlated with postoperative recurrence of choledocholithiasis (P<0.05). Multivariate Logistic analysis showed that the number of calculi, diameter of common bile duct, lithotripsy, common bile duct dilatation, cystic duct dilatation, combined inflammation were independent risk factors for postoperative recurrence of choledocholithiasis (P<0.05). Conclusion Application of LC+LCHTD has significant effect on patients with choledocholithiasis combined with cholecystolithiasis. Postoperative recurrence of choledocholithiasis is influenced by many factors, and active intervention can reduce the recurrence rate.

Key words: choledocholithiasis complicated with cholecystolithiasis laparoscopic cholecystectomy (LC), laparoscopic choledocholithotomy and T-tube drainage (LCHTD), postoperative, recurrence of choledocholithiasis

中图分类号: 

  • R657.4
[1] 王开东, 王雷, 刁先坪, 陆冠一, 范向军.
急性胆囊炎并发胆囊及肝脏破裂出血一例
[J]. 肝胆胰外科杂志, 2023, 35(3): 184-186.
[2] 宣利倩, 吉建梅, 龚彪.
影像学及微创技术在一例胰腺肿瘤诊断中的应用分析
[J]. 肝胆胰外科杂志, 2020, 32(12): 747-749.
[3] 戴碧纯, 潘碧垚, 张珊珊, 庄伟伟, 孙红光. 核酸适配体技术在胰腺癌诊断和治疗中的应用[J]. 肝胆胰外科杂志, 2019, 31(6): 325-328.
[4] 李清华, 崔龙久, 刘双海. 门静脉高压症对伴门静脉癌栓肝癌患者术后生存的影响[J]. 肝胆胰外科杂志, 2019, 31(6): 335-365.
[5] 陈德华, 高志强, 马雪松, 申鹏程, 唐哲. 经皮射频消融治疗复发性肝癌的疗效及预后因素分析[J]. 肝胆胰外科杂志, 2019, 31(6): 340-351.
[6] 龚沛榕, 胡余杰, 范晓东, 胡邓迪, 张炯炯, 陈钢 . 术前营养风险筛查联合营养支持对结直肠癌患者的临床价值[J]. 肝胆胰外科杂志, 2019, 31(6): 344-347.
[7] 邢人伟, 牟永华, 李文巨, 李波, 聂寒秋, 殷平. 超声造影与增强CT在胆囊息肉样病变诊断中的比较[J]. 肝胆胰外科杂志, 2019, 31(6): 356-359.
[8] 张怀波, 马荣龙, 张德景 .
外源性CC10基因表达对肝癌细胞增殖、 凋亡、迁移和侵袭的影响
[J]. 肝胆胰外科杂志, 2019, 31(6): 360-365.
[9] 尤和谊, 蒋飞照, 郑志海 . 腹腔镜胆总管探查T管引流后窦道形成的观察[J]. 肝胆胰外科杂志, 2019, 31(6): 366-373.
[10] 李振宇, 徐文静 . 隐匿性小切口二孔法腹腔镜胆囊切除术[J]. 肝胆胰外科杂志, 2019, 31(6): 368-373.
[11] 慎华平, 曹国良, 周轼瑜, 张国雷, 魏强, 袁文斌, 张鸣杰, 严强 . PTGD联合LC治疗老年急性化脓性胆囊炎临床效果[J]. 肝胆胰外科杂志, 2019, 31(6): 370-373.
[12] 王成达, 吴文娟, 张雷, 陈昉铭. 胰腺动静脉畸形致难治性胰腺炎一例[J]. 肝胆胰外科杂志, 2019, 31(6): 374-375.
[13] 陈文超, 蔡华杰, 杨寿璋, 屠金夫 . 后腹膜副中肾管源性囊肿二例[J]. 肝胆胰外科杂志, 2019, 31(6): 376-377.
[14] 丁浩然, 任昊桢, 施晓雷. MSCs移植治疗肝切除术后肝衰竭的应用及进展[J]. 肝胆胰外科杂志, 2019, 31(6): 378-380.
[15] 高浩, 卫积书, 苗毅. 胰腺导管内乳头状黏液瘤外科手术指征的历史与现状[J]. 肝胆胰外科杂志, 2019, 31(5): 257-260.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © 2017 肝胆胰外科杂志 All Rights Reserved.
电话/传真:0577-86699363 E-mail: gdywkzz@vip.126.com
地址:浙江省温州市茶山高教园区温州医科大学图书馆A411室 邮编:325035
本系统由北京玛格泰克科技发展有限公司设计开发 技术支持:support@magtech.com.cn